Lamotrigin ”viatris” (Lamotrigine)

Lamotrigine works by inhibiting voltage‑gated sodium channels on neuronal membranes, which reduces the release of excitatory neurotransmitters such as glutamate. This action dampens abnormal electrical activity in the brain, helping to prevent seizures and modulate mood‑related pathways.

The appropriate dose of Lamotrigin is individualized by the prescribing clinician based on the patient’s age, weight, indication, and any concomitant medications. Dosage titration is typically gradual to minimise the risk of skin reactions, and the prescriber determines the final regimen.

The safety of lamotrigine in pregnancy and lactation is not fully established. It is classified as having an unknown pregnancy category, so clinicians weigh potential benefits against possible risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and monitoring plans with their healthcare provider.

To request Lamotrigin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older antiepileptics such as carbamazepine or phenytoin, lamotrigine offers a broader spectrum for both focal and generalized seizures and has mood‑stabilising properties useful in bipolar disorder. However, it requires slower titration and careful monitoring for skin reactions, whereas some alternatives may have different side‑effect profiles.

Lamotrigin tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct light. Keeping the product in a dry, cool environment helps maintain its potency throughout its shelf life.

Lamotrigin is taken orally, usually as a tablet, with or without food. The exact dosing schedule—once or twice daily—depends on the prescriber’s instructions and the patient’s individual treatment plan.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood disorders like agranulocytosis, and rare cases of hepatic failure. Patients should seek immediate medical attention if they develop rash, fever, unexplained bruising, or signs of liver dysfunction.

Lamotrigin is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Caution is also advised for patients with severe hepatic impairment, those taking strong enzyme‑inducing drugs without dose adjustment, and pregnant or nursing women unless the benefits outweigh potential risks.